Loading...
Loading...
Among the 6 tracked institutional investors we monitor, PTGX (PROTAGONIST THERAPEUTICS INC) is held with a combined value of $1.92B across 19,136,781 shares. The largest holder is BlackRock, Inc. with a position worth $1.03B (0.02% of their portfolio). 4 funds opened new positions in the most recent quarter. 1 fund increased its holdings. 1 fund reduced its position.
Total Institutional Value
$1.92B
Total Shares Held
19,136,781
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $1.03B | 0.02% | New |
| 2 | VANGUARD GROUP INC | $472.83M | 0.01% | New |
| 3 | STATE STREET CORP | $328.51M | 0.01% | -2.6% |
| 4 | FMR LLC | $69.77M | 0.00% | +22.6% |
| 5 | Duquesne Family Office LLC | $16.83M | 0.50% | New |
| 6 | Bridgewater Associates, LP | $556.09K | 0.00% | New |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of PTGX with a position worth $1.03B, representing 0.02% of their portfolio. In total, 6 institutional investors hold PTGX with a combined value of $1.92B.
In the most recent quarter, 4 funds opened a new position in PTGX. Additionally, 1 increased their holdings and 1 reduced their positions.
Institutional investors hold $1.92B worth of PTGX stock across 6 positions. The largest institutional holder is BlackRock, Inc. with $1.03B in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For PTGX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their PTGX positions.